TeamViewer (TMV) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Dec, 2025Executive summary
Achieved 9% year-over-year revenue growth in FY 2024 (constant currency), exceeding guidance, with all regions contributing and Enterprise segment showing strong momentum.
Enterprise revenue grew 38% year-over-year in Q4 and 24% for FY 2024, driven by large deals and high-value contracts.
Adjusted EBITDA increased 14% year-over-year to €296.7m, with margin at 44% for FY 2024 and 47% in Q4, supported by cost discipline.
Acquisition of 1E closed in January 2025, expanding digital employee experience capabilities; integration is underway and expected within 12 months.
Pro forma FY 2025 guidance: revenue €778m–€797m, ARR €815m–€840m, adjusted EBITDA margin around 43%.
Financial highlights
FY 2024 revenue: €671.4m (+9% constant currency), ARR: €684.1m (+7%), billings: €699.7m (+3%).
Adjusted EBITDA: €296.7m (+14%), margin: 44%; adjusted EPS: €1.05 (+20%); net income: €123.1m (+8%).
Levered free cash flow: €215.3m (+8%); cash conversion (FCFE/adjusted EBITDA): 73%.
Q4 2024 revenue: €177m (+9% YoY); Q4 adjusted EBITDA margin: 47%.
1E delivered €73.4m ARR (+30%) and €68.6m revenue (+23%) with a 27% adjusted EBITDA margin.
Outlook and guidance
FY 2025 pro forma guidance: ARR €815m–€840m (+7.5–10.8%), revenue €778m–€797m (+5.1–7.7%), adjusted EBITDA margin ~43%.
Standalone 2025 revenue guidance: TeamViewer €697m–€712m, 1E €81m–€85m.
Midterm targets: revenue €1,030m–€1,060m by 2028, Enterprise share above 40%, and adjusted EBITDA margin 44–45%.
Net leverage ratio expected to decrease below 2.0x by end of 2026.
FY 2025 SMB ARR: €550m–€565m; Enterprise ARR: €265m–€275m.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025